|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Saudi Arabia's finance minister says artificial intelligence, data mining and augmented reality is where it's targeting a massive spending push.
In this article, I’m going to take a look at Eleven Biotherapeutics Inc’s (NASDAQ:EBIO) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...
This weekend's Barron's cover story examines the divide between business models in the big tech space. Other featured articles show why MLPs look attractive again and what to expect in the battle over ...
As large tech companies report first-quarter earnings in a flood of results during the next two weeks, they face a major test: Will they continue to post huge growth, and fuel further overall gains for ...
Sarepta Therapeutics (SRPT) posted $231.9 million in operating activities in fiscal 2017 compared with $245.8 million in fiscal 2016. This decrease of $13.8 million in fiscal 2017 was primarily due to a decrease of $91.6 million in a net loss. This trend was driven by higher product revenues of Exondys and a decrease in research and development expenses due to capitalization of inventory.
A telecommunications standards organization - GSMA - said on Saturday it is delaying implementation of a new cellphone technology due to a U.S. government probe of alleged coordination between the group, AT&T Inc (T.N) and Verizon Communications Inc (VZ.N) to hinder consumers from easily switching wireless carriers. At issue is a technology that could make carriers' business more volatile.
A telecommunications standards organization - GSMA - said on Saturday it is delaying implementation of a new cellphone technology due to a U.S. government probe of alleged coordination between the group, AT&T Inc and Verizon Communications Inc to hinder consumers from easily switching wireless carriers. At issue is a technology that could make carriers' business more volatile.
Apple ended a rough week by announcing that a fault in some MacBook Pro laptops have a faulty component that “may fail causing the built-in battery to expand.” It is not a safety issue, the company added. A “limited number” of 13-inch MacBook Pro models (without a Touch Bar) built between October 2016 and October…
How Is Sarepta Therapeutics Positioned in 2018? Sarepta Therapeutics (SRPT) generated revenues of $154.5 million in fiscal 2017 compared with $5.4 million in fiscal 2016. The substantial increase in revenues shows the increasing demand for the product.